NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

In vitro selection of oligoribonucleotides which bind to HIV-1 RNA.

Johnson L, McPhee D, Purcell D; Australasian Society for HIV Medicine. Conference.

Annu Conf Australas Soc HIV Med. 1996 Nov 14-17; 8: 116 (poster no. 133).

Macfarlane Burnet Centre for Medical Research, Fairfield, Victoria.

Human immunodeficiency virus type-1 (HIV-1) RNA undergoes a variety of post-transcriptional processing events, each of which represents a potential intervention point for antiviral therapy. Antisense oligonucleotides, ribozymes and antisense messenger RNAs have all been used to inhibit HIV-1 replication in vitro. Selection techniques have been used in developing these antiviral agents that involve mutagenesis and selection of the most effective antiviral molecules. We aimed to extend the generation of high affinity oligonucleotides and oligoribonucleotides by in vitro selection. We have developed a technique for generating oligoribonucleotide pools of random sequence and length that bind to HIV-1 RNA. Oligonucleotides were designed with fixed 5' ends that include either a T7 or SP6 RNA polymerase binding site and fixed 3' ends with intervening random sequences. These oligonucleotides were used to self anneal in a polymerase chain reaction (PCR) to generate random, double-stranded oligonucleotides of variable or fixed length, depending on conditions used. Oligonucleotides or transcribed oligoribonucleotides were mixed with HIV-1 RNA, separated by electrophoresis, and the HIV-1 binding nucleotide sequences recovered by a reverse-transcriptase PCR reaction. The technique allows identification and characterization of the most exposed regions of RNA. It is therefore useful as an analytical tool for studying HIV-1 RNA secondary structure along with identifying new targets for antiviral therapy.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Base Sequence
  • DNA-Directed RNA Polymerases
  • HIV-1
  • Humans
  • In Vitro
  • Oligonucleotides
  • Oligonucleotides, Antisense
  • Oligoribonucleotides
  • Polymerase Chain Reaction
  • RNA
  • RNA Processing, Post-Transcriptional
  • RNA polymerase SP6
  • RNA, Antisense
  • RNA, Catalytic
  • RNA, Complementary
  • RNA, Messenger
  • RNA-Directed DNA Polymerase
  • Selection (Genetics)
  • genetics
  • reverse transcriptase, Human immunodeficiency virus 1
Other ID:
  • 97153716
UI: 102221971

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov